Picking up a quest abandoned by Big Pharma, academic labs are using new technology to develop contraceptive drugs for men.
Somewhere in Martin Matzuk's collection of two billion chemicals, he hopes, is one that might safely make a man temporarily sterile—the elusive “male pill.”
